Joe Posted June 15, 2021 Author Share Posted June 15, 2021 2 hours ago, Air_Delivery said: mRNA are still a bit more effective but the advantages of delivery that Novavax has should give Pfizer and Moderna real competition. The problem is that they are way behind. They aren’t at all more effective. These efficacy numbers are against the new variants. Quote Link to comment Share on other sites More sharing options...
Joe Posted June 24, 2021 Author Share Posted June 24, 2021 Novavax Is Now the Best COVID-19 Vaccine - The Atlantic WWW.THEATLANTIC.COM Persistent hype around mRNA vaccine technology is now distracting us from other ways to end the pandemic. Quote Link to comment Share on other sites More sharing options...
Commissar SFLUFAN Posted February 28, 2023 Share Posted February 28, 2023 18 months later... Novavax raises doubts about its ability to remain in business WWW.CNBC.COM Covid-19 vaccine maker Novavax on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending. Quote Covid-19 vaccine maker Novavax on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending as it works to prepare for a fall vaccination campaign. The company said there is significant uncertainty around its 2023 revenue, funding from the U.S. government, and pending arbitration with global vaccine alliance GAVI. But its cash flow forecast indicates it has sufficient capital to fund operations over the next year. The company lost $182 million, or $2.28 per share, in the fourth quarter on weaker-than-expected sales of $357 million. Analysts had expected sales of $383 million, according to Refinitiv data. “If we execute on our operating plan, we’ll be in a very strong position not only at the end of this year, but going into next year,” Novavax’s new Chief Executive John Jacobs, who joined the company in late January, said in an interview. Novavax had $1.33 billion of cash on hand at the end of 2022. However, Jacobs cautioned that there are risks in the near term to that operating plan, including the fact that protein-based vaccines like Novavax’s take longer to produce than their messenger RNA-based competitors. Quote Link to comment Share on other sites More sharing options...
Guest Posted February 28, 2023 Share Posted February 28, 2023 Hope @Joecollected his tendies while he could Quote Link to comment Share on other sites More sharing options...
Joe Posted February 28, 2023 Author Share Posted February 28, 2023 My tendies are worth less than one of their vaccines without insurance unfortunately. Quote Link to comment Share on other sites More sharing options...
Jason Posted March 1, 2023 Share Posted March 1, 2023 43 minutes ago, Joe said: My tendies are worth less than one of their vaccines without insurance unfortunately. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.